Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (8065)	6/9/1998 1:12:00 AM
From: John Metcalf	Read Replies (1) \| Respond to of 9262

>>Have you folks had enough biotech yet??? >> Nope .. not yet. Recently, Hoescht announced plans to sell its fibers business and become a life sciences business. DuPont announced plans to sell out of oil (Conoco) and become a life sciences business. AHP bought Monsanto, becoming a broader life sciences business. Merck sold its stakes in DuPont-Merck and Astra-Merck. While stating it was not looking for mergers and acquisitions, Merck did say it would be looking for collaborations. There is a megaton of big money pointed at the biotech sector, which has been catching a cold while the market has been sneezing. Though long term, the entry of four big players should be good for the industry, particularly if the gorillas compete with each other.